CCL2 and glioblastoma: Although no difference in Treg influx was observed with anti-CCL2 [68], suggesting possible compensatory roles of other chemokines in Treg mobilisation, Ccl2-/- mice intracranially implanted with glioblastoma tumour cells had reduced infiltrating Tregs and monocytic MDSCs [67].